Return to homepagePandemic Pact

Developing processes to manufacture vaccines at scale

  • Funded by Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $460,000

  • Funder

    Department of Health and Social Care / National Institute for Health and Care Research (DHSC-NIHR)

  • Principal Investigator

    Dr. Sandy Douglas

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Oxford

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine logistics and supply chains and distribution strategies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The team is aiming to develop manufacturing processes for producing adenovirus vaccines at a million-dose scale, so that - if clinical trials are successful - a vaccine could be made available to high-risk groups as quickly as possible. They are working with Professor Sarah Gilbert's team, who are developing promising novel coronavirus vaccines by modifying harmless adenoviruses.